BDBM20790 2-amino-6-halopurine analogue, 18b::9-[(2-bromo-3,4,5-trimethoxyphenyl)methyl]-6-chloro-9H-purin-2-amine
SMILES: COc1cc(Cn2cnc3c(Cl)nc(N)nc23)c(Br)c(OC)c1OC
InChI Key: InChIKey=PFLBIBKFAHQQGR-UHFFFAOYSA-N
Data: 1 EC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Heat shock protein HSP 90-beta (Homo sapiens (Human)) | BDBM20790 (2-amino-6-halopurine analogue, 18b | 9-[(2-bromo-3...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | n/a | n/a | 70 | n/a | n/a | 7.2 | 37 |
Biogen Idec | Assay Description EC50 was defined as the concentration of the compound at which there was 50% degradation of the Her-2/neu protein in MCF7 breast carcinoma cells. Sam... | J Med Chem 50: 2767-78 (2007) Article DOI: 10.1021/jm050752+ BindingDB Entry DOI: 10.7270/Q22Z13ST | |||||||||||
More data for this Ligand-Target Pair |